HK Stock MarketDetailed Quotes

02137 BRII-B

Watchlist
  • 0.900
  • +0.010+1.12%
Not Open Dec 13 16:08 CST
658.16MMarket Cap-2.26P/E (TTM)

BRII-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Advance deposits and other receivables
-7.41%99.49M
56.35%121.39M
51.27%107.45M
31.86%77.64M
61.47%71.03M
72.57%58.88M
--43.99M
618.47%34.12M
--4.75M
Cash and equivalents
34.62%656.26M
-58.87%489.65M
-83.57%487.49M
-58.30%1.19B
105.30%2.97B
175.86%2.86B
--1.44B
17.56%1.03B
--880.36M
Fixed time deposit-current assets
-23.14%1.73B
20.16%2.17B
788.92%2.25B
261.62%1.81B
--253.28M
2,398.24%499.65M
----
--20M
----
Secured deposit
3,657.84%73.09M
-61.12%729K
-21.38%1.95M
487.77%1.88M
665.94%2.47M
-91.51%319K
--323K
976.50%3.76M
--349K
Total current assets
-10.15%2.56B
-9.56%2.78B
-13.50%2.85B
-9.87%3.08B
121.13%3.29B
212.39%3.41B
--1.49B
23.42%1.09B
--885.46M
Non-current assets
Property, plant and equipment
-97.32%127K
-71.18%2.12M
-52.50%4.73M
-41.58%7.35M
-37.21%9.96M
-23.83%12.57M
--15.86M
-22.63%16.51M
--21.33M
Advance payment
1,013.34%25.21M
----
-18.74%2.26M
-9.80%2.51M
-8.05%2.79M
15.41%2.79M
--3.03M
4.19%2.41M
--2.32M
Secured deposits-non-current assets
--17.93M
----
----
----
----
----
----
----
----
Financial assets at fair value-non-current assets
-92.45%14.21M
-3.74%134.56M
46.00%188.26M
18.68%139.79M
72.81%128.95M
56.29%117.79M
--74.62M
3.54%75.37M
--72.79M
Intangible assets
85.28%268.88M
82.06%267.42M
1,681.05%145.12M
1,445.20%146.89M
-25.00%8.15M
-22.22%9.51M
--10.86M
--12.22M
----
Total non-current assets
-3.65%337.26M
31.92%415.47M
95.73%350.03M
59.26%314.95M
-0.79%178.84M
12.94%197.76M
--180.27M
13.73%175.1M
--153.97M
Total assets
-9.43%2.9B
-5.71%3.2B
-7.88%3.2B
-6.09%3.39B
107.97%3.47B
184.85%3.61B
--1.67B
21.99%1.27B
--1.04B
Liabilities
Current liabilities
Other payables and accrued expenses
-56.02%37.77M
-56.30%72.08M
-68.34%85.87M
-24.64%164.94M
131.45%271.24M
-56.00%218.86M
--117.19M
2,709.16%497.39M
--17.71M
Financial lease liabilities-current liabilities
-86.26%1.1M
-66.78%3.16M
-13.69%8M
5.92%9.5M
0.22%9.27M
11.82%8.97M
--9.25M
-0.61%8.02M
--8.07M
Deferred income-current liabilities
62.75%28.83M
-7.40%50.63M
-36.38%17.71M
3.39%54.68M
3.88%27.84M
-24.26%52.88M
--26.8M
93.38%69.82M
--36.11M
Total current liabilities
-39.33%67.7M
-45.06%125.87M
-63.81%111.58M
-18.38%229.11M
101.22%308.35M
-51.20%280.71M
--153.24M
829.54%575.24M
--61.88M
Net current assets
-8.96%2.49B
-6.70%2.66B
-8.31%2.74B
-9.11%2.85B
123.42%2.98B
505.33%3.13B
--1.34B
-37.15%517.61M
--823.57M
Total assets less current liabilities
-8.35%2.83B
-2.86%3.07B
-2.42%3.09B
-5.05%3.16B
108.65%3.16B
380.86%3.33B
--1.52B
-29.14%692.71M
--977.54M
Non-current liabilities
Financial lease liabilities-non-current liabilities
--800K
----
----
-75.05%3.16M
-54.84%8.2M
-37.72%12.65M
--18.17M
-24.91%20.31M
--27.04M
Deferred income-non-current liabilities
----
----
----
-70.59%2.08M
-52.18%4.58M
-41.38%7.08M
--9.58M
-56.72%12.08M
--27.92M
Convertible notes and bonds
--17.82M
----
----
----
----
----
----
----
----
Special items of non-current liabilities
----
----
----
----
----
----
--6.13B
56.51%2.4B
--1.54B
Total non-current liabilities
--18.62M
----
----
-73.45%5.24M
-99.79%12.79M
-99.19%19.73M
--6.15B
53.14%2.44B
--1.59B
Total liabilities
-22.65%86.31M
-46.29%125.87M
-65.25%111.58M
-22.00%234.35M
-94.91%321.14M
-90.02%300.44M
--6.31B
82.22%3.01B
--1.65B
Total assets less total liabilities
-8.96%2.81B
-2.70%3.07B
-2.03%3.09B
-4.64%3.16B
167.95%3.15B
290.01%3.31B
---4.64B
-184.40%-1.74B
---612.76M
Total equity and non-current liabilities
--2.83B
----
----
-5.05%3.16B
108.65%3.16B
380.86%3.33B
--1.52B
-29.14%692.71M
--977.54M
Equity
Share capital
0.00%24K
0.00%24K
4.35%24K
4.35%24K
228.57%23K
228.57%23K
--7K
0.00%7K
--7K
Share premium
-8.66%2.86B
-2.37%3.12B
-2.17%3.13B
-4.44%3.19B
169.09%3.2B
292.31%3.34B
---4.63B
-183.68%-1.74B
---612.77M
Shareholders' Equity
-8.66%2.86B
-2.37%3.12B
-2.17%3.13B
-4.44%3.19B
169.09%3.2B
292.31%3.34B
---4.63B
-183.68%-1.74B
---612.76M
Non-controlling interest
-12.12%-49.36M
-25.71%-46.66M
11.37%-44.03M
-17.28%-37.12M
-931.67%-49.68M
-617.15%-31.65M
---4.82M
---4.41M
----
Total equity
-8.96%2.81B
-2.70%3.07B
-2.03%3.09B
-4.64%3.16B
167.95%3.15B
290.01%3.31B
---4.64B
-184.40%-1.74B
---612.76M
Total equity and total liabilities
-9.43%2.9B
-5.71%3.2B
-7.88%3.2B
-6.09%3.39B
107.97%3.47B
184.85%3.61B
--1.67B
21.99%1.27B
--1.04B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Advance deposits and other receivables -7.41%99.49M56.35%121.39M51.27%107.45M31.86%77.64M61.47%71.03M72.57%58.88M--43.99M618.47%34.12M--4.75M
Cash and equivalents 34.62%656.26M-58.87%489.65M-83.57%487.49M-58.30%1.19B105.30%2.97B175.86%2.86B--1.44B17.56%1.03B--880.36M
Fixed time deposit-current assets -23.14%1.73B20.16%2.17B788.92%2.25B261.62%1.81B--253.28M2,398.24%499.65M------20M----
Secured deposit 3,657.84%73.09M-61.12%729K-21.38%1.95M487.77%1.88M665.94%2.47M-91.51%319K--323K976.50%3.76M--349K
Total current assets -10.15%2.56B-9.56%2.78B-13.50%2.85B-9.87%3.08B121.13%3.29B212.39%3.41B--1.49B23.42%1.09B--885.46M
Non-current assets
Property, plant and equipment -97.32%127K-71.18%2.12M-52.50%4.73M-41.58%7.35M-37.21%9.96M-23.83%12.57M--15.86M-22.63%16.51M--21.33M
Advance payment 1,013.34%25.21M-----18.74%2.26M-9.80%2.51M-8.05%2.79M15.41%2.79M--3.03M4.19%2.41M--2.32M
Secured deposits-non-current assets --17.93M--------------------------------
Financial assets at fair value-non-current assets -92.45%14.21M-3.74%134.56M46.00%188.26M18.68%139.79M72.81%128.95M56.29%117.79M--74.62M3.54%75.37M--72.79M
Intangible assets 85.28%268.88M82.06%267.42M1,681.05%145.12M1,445.20%146.89M-25.00%8.15M-22.22%9.51M--10.86M--12.22M----
Total non-current assets -3.65%337.26M31.92%415.47M95.73%350.03M59.26%314.95M-0.79%178.84M12.94%197.76M--180.27M13.73%175.1M--153.97M
Total assets -9.43%2.9B-5.71%3.2B-7.88%3.2B-6.09%3.39B107.97%3.47B184.85%3.61B--1.67B21.99%1.27B--1.04B
Liabilities
Current liabilities
Other payables and accrued expenses -56.02%37.77M-56.30%72.08M-68.34%85.87M-24.64%164.94M131.45%271.24M-56.00%218.86M--117.19M2,709.16%497.39M--17.71M
Financial lease liabilities-current liabilities -86.26%1.1M-66.78%3.16M-13.69%8M5.92%9.5M0.22%9.27M11.82%8.97M--9.25M-0.61%8.02M--8.07M
Deferred income-current liabilities 62.75%28.83M-7.40%50.63M-36.38%17.71M3.39%54.68M3.88%27.84M-24.26%52.88M--26.8M93.38%69.82M--36.11M
Total current liabilities -39.33%67.7M-45.06%125.87M-63.81%111.58M-18.38%229.11M101.22%308.35M-51.20%280.71M--153.24M829.54%575.24M--61.88M
Net current assets -8.96%2.49B-6.70%2.66B-8.31%2.74B-9.11%2.85B123.42%2.98B505.33%3.13B--1.34B-37.15%517.61M--823.57M
Total assets less current liabilities -8.35%2.83B-2.86%3.07B-2.42%3.09B-5.05%3.16B108.65%3.16B380.86%3.33B--1.52B-29.14%692.71M--977.54M
Non-current liabilities
Financial lease liabilities-non-current liabilities --800K---------75.05%3.16M-54.84%8.2M-37.72%12.65M--18.17M-24.91%20.31M--27.04M
Deferred income-non-current liabilities -------------70.59%2.08M-52.18%4.58M-41.38%7.08M--9.58M-56.72%12.08M--27.92M
Convertible notes and bonds --17.82M--------------------------------
Special items of non-current liabilities --------------------------6.13B56.51%2.4B--1.54B
Total non-current liabilities --18.62M---------73.45%5.24M-99.79%12.79M-99.19%19.73M--6.15B53.14%2.44B--1.59B
Total liabilities -22.65%86.31M-46.29%125.87M-65.25%111.58M-22.00%234.35M-94.91%321.14M-90.02%300.44M--6.31B82.22%3.01B--1.65B
Total assets less total liabilities -8.96%2.81B-2.70%3.07B-2.03%3.09B-4.64%3.16B167.95%3.15B290.01%3.31B---4.64B-184.40%-1.74B---612.76M
Total equity and non-current liabilities --2.83B---------5.05%3.16B108.65%3.16B380.86%3.33B--1.52B-29.14%692.71M--977.54M
Equity
Share capital 0.00%24K0.00%24K4.35%24K4.35%24K228.57%23K228.57%23K--7K0.00%7K--7K
Share premium -8.66%2.86B-2.37%3.12B-2.17%3.13B-4.44%3.19B169.09%3.2B292.31%3.34B---4.63B-183.68%-1.74B---612.77M
Shareholders' Equity -8.66%2.86B-2.37%3.12B-2.17%3.13B-4.44%3.19B169.09%3.2B292.31%3.34B---4.63B-183.68%-1.74B---612.76M
Non-controlling interest -12.12%-49.36M-25.71%-46.66M11.37%-44.03M-17.28%-37.12M-931.67%-49.68M-617.15%-31.65M---4.82M---4.41M----
Total equity -8.96%2.81B-2.70%3.07B-2.03%3.09B-4.64%3.16B167.95%3.15B290.01%3.31B---4.64B-184.40%-1.74B---612.76M
Total equity and total liabilities -9.43%2.9B-5.71%3.2B-7.88%3.2B-6.09%3.39B107.97%3.47B184.85%3.61B--1.67B21.99%1.27B--1.04B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor --Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public AccountantsDeloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-2.21%